This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Events & Webinars
  • Podcasts
  • Resources
  • Learning Zone
  • Products
  • Service Optimisation & Formularies
  • Risk Minimisation Materials
Cardiovascular
Cardiovascular
Womens Health
Women's Health
two kidneys
Nephrology
Oncology
Oncology
Ophthalmology
Ophthalmology
Respiratory
Respiratory
Bayer cross colorful
Bayer for ProfessionalsYour Resource Portal
closesearch
Recent Searches
    You are now leaving BayerPro

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    Welcome to the HF-IMPACT Hub

    Our HF-IMPACT hub has been developed with the aim of improving management and prognosis through advance cardiac training. 

    Here you can access all our Resources, Upcoming Events and On-Demand Webinars which focus on Heart Failure (HF) topics; including Transthyretin Amyloid Cardiomyopathy (ATTR-CM).

    ATTR-CM Resources

    Navigating ATTR-CM Diagnosis
    Beyonttra®▼ (acoramidis) | Explore resources on Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Beyonttra Prescribing Information
    PP-PF-CAR-GB-0060, October 2025

    Related Products

    Beyonttra®▼ (acoramidis) - Overview
    About Beyonttra
    Beyonttra (acoramidis) Prescribing Information
    PP-BEY-GB-0001, May 2025

    Register with BayerPRO

    To access additional resources, personalise your experience and keep up to date via electronic communications from Bayer.

     

    PP-BEY-GB-0074 | October 2025